Status:
COMPLETED
Patient Navigator Intervention for Diabetic Retinopathy
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Eye Institute (NEI)
Conditions:
Diabetic Retinopathy
Diabetic Blindness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a pilot study of a patient navigator intervention for people living with diabetes and at high risk of diabetic blindness. The investigators are assessing the feasibility and acceptability of t...
Detailed Description
Evidence-based treatment for Diabetic retinopathy (DR) established 30 years ago decreases the likelihood of blindness by 50%. Outcomes are even better now with emerging therapies and technology. Diabe...
Eligibility Criteria
Inclusion
- Adults aged 18 and over
- Diagnosis of diabetes and record of diagnosis in YNHHS EPIC
- English-speaking
- No documented eye examination within 1 year of study enrollment
- High risk for diabetic retinopathy based on risk calculator evaluation
Exclusion
- Documented eye exam in the past year
- Not high risk for diabetic retinopathy
- Diabetes diagnosis not recorded in EPIC
Key Trial Info
Start Date :
July 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 19 2024
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT05188703
Start Date
July 25 2022
End Date
September 19 2024
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale School of Medicine
New Haven, Connecticut, United States, 06511